Professional virtual currency information station welcome
We have been making efforts.
2 Articles

Tags :Annual Report Interpretation

Interpretation Of Lisheng Pharmaceutical's 2025 Annual Report: Revenue And Profits Double, And Fruitful R&D Results

On March 24, Lisheng Pharmaceuticals announced its 2025 annual report. The company's operating income was 1.39 billion yuan, a year-on-year increase of 4.2%; the net profit attributable to the parent company was 416 million yuan, a year-on-year increase of 125.6%; the net profit after non-attribution to the parent company was 169 million yuan, a year-on-year increase of 63

Interpretation Of Maiwei Biotech's 2025 Annual Report: Revenue Increases, Losses Decrease, R&D Investment Is High, And There Are Many Varieties

On March 24, Maiwei Biotech announced its 2025 annual report. The company's operating income was 663 million yuan, a year-on-year increase of 231.6%; the net profit attributable to the parent company increased from a loss of 1.04 billion yuan in the same period last year to a loss of 969 million yuan.

Sign In

Forgot Password

Sign Up